Expand UTHR Menu
UTHR MENU

UTHR Stock Summary and Trading Ideas (United Therapeutics | NASDAQ:UTHR)

Charts for Today's Stock Price and Implied Volatility in United Therapeutics

18-Apr-2024

Stock Price & Volume | Full Chart

30-Day Implied Volatility | IV30 Full Chart

Trade Ideas for Best Option Strategies for UTHR by Theoretical Edge and Win Rates

Sentiment

Trading Statistics

Key Ratios

United Therapeutics (UTHR) Frequently Asked Questions

What does United Therapeutics do?

United Therapeutics specializes in drug development for pulmonary arterial hypertension, a rare and progressive disease marked by abnormally high blood pressure in the arteries of the lungs. The company's therapies for PAH largely focus on the prostacyclin pathway, and many of its treatments are based on the same molecule, treprostinil. Most of the company's sales are generated within the United States. United Therapeutics also markets a pediatric oncology drug, but its focus largely remains in pulmonary arterial hypertension.

What symbol and exchange does United Therapeutics stock trade?

United Therapeutics trades on the NASDAQ stock market under the symbol UTHR.

What is United Therapeutics stock price doing today?

As of April 18, 2024, UTHR stock price climbed to $236.93 with 430,289 million shares trading.

What is United Therapeutics's Beta?

UTHR has a beta of 0.67, meaning it tends to be less sensitive to market movements. UTHR has a correlation of 0.09 to the broad based SPY ETF.

How much is United Therapeutics worth?

UTHR has a market cap of $11.15 billion. This is considered a Large Cap stock.

How much money does United Therapeutics make?

Last quarter United Therapeutics reported $615 million in Revenue and $4.36 earnings per share. This beat revenue expectation by $39 million and exceeded earnings estimates by $.17.

What is the highest and lowest price United Therapeutics traded in the last 3 year period?

In the last 3 years, UTHR stock traded as high as $283.09 and as low as $158.38.

What are the top ETFs holding United Therapeutics?

The top ETF exchange traded funds that UTHR belongs to (by Net Assets): IJH, VTI, VB, VBR, VXF.

Is United Therapeutics (UTHR) a good investment?

UTHR stock has underperformed the market in the last year with a return of +3.9%, while SPY returned +22.2%. This shows that you would have done better investing in the overall market (through SPY) over the last year than in UTHR shares. However, UTHR has outperformed the market in the last 3 month and 2 week periods, returning +8.1% and +1.3%, while SPY returned +5.2% and -2.6%, respectively. This indicates UTHR has been having a stronger performance recently.

What is the support and resistance for United Therapeutics (UTHR) stock price?

UTHR support price is $230.68 and resistance is $239.94 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that UTHR stock will trade within this expected range on the day.